Add BrightSurf on Google Email

Science News Archive 2021 - Page 304


Page 304 of 510

Indigenous peoples in Canada have higher death rates, complications after surgery

New research published in CMAJ found Indigenous peoples in Canada experience higher rates of complications after surgery, lower surgery rates, and longer wait times for life-saving procedures. The study highlights the need for better data collection methods and real-time outcome monitoring to address structural racism in healthcare.

SourceCanadian Medical Association Journal·JournalCanadian Medical Association Journal·DateMay 17, 2021

Finerenone may delay onset of AFib in patients with chronic kidney disease, diabetes

Researchers found that finerenone reduced the risk of atrial fibrillation by 30% in patients with chronic kidney disease and Type 2 diabetes, regardless of their history with AFib. The study suggests that finerenone can delay the onset of heart rhythm disorder and protect the heart and kidneys from further damage.

SourceAmerican College of Cardiology·JournalJournal of the American College of Cardiology·DateMay 17, 2021

New medical image fusion method draws on deep learning to improve patient outcomes

Researchers developed a new multi-modal image fusion method based on supervised deep learning to enhance image clarity, reduce redundant features, and support batch processing. The method achieves state-of-the-art performance in visual quality and quantitative evaluation metrics, improving medical diagnosis accuracy.

SourceKeAi Communications Co., Ltd.·JournalInternational Journal of Cognitive Computing in Engineering·DateMay 16, 2021

Tailored cardiac rehab program improves function and quality of life in older heart failure patients

A novel 12-week physical rehabilitation program tailored to address specific physical impairments in older heart failure patients improved physical functioning, quality of life, and depression. However, participation did not significantly reduce rehospitalizations during the six-month follow-up period.

SourceAmerican College of Cardiology·JournalNew England Journal of Medicine·DateMay 16, 2021

Rivaroxaban reduces first and total ischemic events in patients with peripheral artery disease

The study found that rivaroxaban significantly reduced the occurrence of total severe events in patients with symptomatic peripheral artery disease who underwent lower extremity revascularization. The treatment also showed a 12.5% absolute reduction in risk for adverse events in this high-risk population.

SourceAmerican College of Cardiology·JournalJournal of the American College of Cardiology·DateMay 16, 2021